CEBPZ and acute myeloid leukemia: The core binding factor AML (CBF-AML) with t(8;21) (q22;q22) or inv(16) (p13q22)/t(16;16), are considered to have a good prognosis, although the 3-year OS is 60% for inv(16) and 40% for t(8;21).